-
1 Comment
EL.En. S.p.A is currently in a long term uptrend where the price is trading 44.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
EL.En. S.p.A's total revenue rose by 18.8% to $140M since the same quarter in the previous year.
Its net income has increased by 310.7% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $11M since the same quarter in the previous year.
Based on the above factors, EL.En. S.p.A gets an overall score of 4/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | None |
Sector | Healthcare |
Industry | Medical Devices |
Beta | 2.13 |
---|---|
Market Cap | 4B |
PE Ratio | 31.81 |
Target Price | None |
Dividend Yield | 0.8% |
EL.En. S.p.A. engages in the research and development, manufacture, distribution, and sale of laser systems in Europe and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; and laser sources and systems for cutting, welding, marking, and engraving on countless materials. It also provides laser sources that include liquid, solid, semiconductor, and gas; and after-sales services, such as supplying of spare parts, as well as consulting and technical assistance services. The company was founded in 1981 and is headquartered in Calenzano, Italy.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for EE51.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025